Evaluation of sialic acid and α-neuraminidase activity in normal and pathological endometrium

Journal of Obstetrics and Gynaecology

Volumn 16, Issue 4, 1996, Pages 265-268

  Vitaioli, L ^a   Baldoni, E ^a   Indraccolo, S R ^b   Antuzzi, D ^c   Ricci, R ^c  

^a UNIVERSITY OF CAMERINO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA NEURAMINIDASE; GLYCOLIPID; GLYCOPROTEIN; SIALIC ACID; SIALIDASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; HYPERPLASIA; MEMBRANE STRUCTURE; MENSTRUAL CYCLE; PRIORITY JOURNAL; UTERUS DISEASE;

EID: 0029802766     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.3109/01443619609020729     Document Type: Article

References (28)

1. Dennis J. W. and Laferte S. (1987) Tumor cell surface carbohydrate and the metastatic phenotype. Cancer Metastasis Reviews, 5, 182-204.
2. Dnistrian A. M., Schwartz M. K., Katopodis N., Fracchia A. A. and Stock C. C. (1982) Serum lipid hound sialic acid as a marker of breast cancer. Cancer, 50, 1815-1819.
3. Dwivedi C., Dixit M., Kumar S. S., Reddy H., Semenya K. A. and Hardy R. E. (1987) Plasma sialic acid alterations in neoplastic tissue. Journal of Medicine, 18, 323-332.
4. Erbil K. M., Jones J. D. and Klee G. G. (1984) Use and limitations of serum total and lipid-bound sialic acid concentrations as markers for colorectal cancer. Anticancer Research, 4, 3-6.
5. Hakomori S. I. (1984) Tumor-associated carbohydrate antigens. Annual Review of Immunology, 2, 103-126.
6. Hogan-Ryan A., Fennelly J. J., Jones M., Cantwell B. and Duffy M. J. (1980) Serum sialic acid and CEA concentrations in human breast cancer. British Journal of Cancer, 41, 587-592.
7. Khadapkur S. V., Sheth N. A. and Bhide S. V. (1975) Independence of sialic acid levels in normal and malignant growth. Cancer Research, 35, 1520-1523.
8. Lipton A., Harvey H. A., DeLong S., Allegra J., White D., Allegra M. and Davidson E. A. (1979) Glycoproteins and human cancer. I. Circulating levels in cancer serum. Cancer, 43, 1766-1771.
9. Millett J. A., Chin Y., Bitensky L., Chayen J. and Husain O. (1980) Lysosomal naphthylamidase activity as a possible aid in cytological screening. Journal of Clinical Pathology, 33, 684-687.
10. Moschl P. and Lubec G. (1981) Basalmembranabban durch Enzyme der 800 Glysosomen-fraktion von Zervix-karzinomzellen. Onkologie, 3, 137-142.
11. Müeller T. O., Henry W. M., Haley L. L., Byers M. G., Eddy R. L. and Shows T. B. (1986) Sialidasis and galactosidasis: chromosomal assignment of two genes associated with neuraminidase-deficiency disorders. Proceedings of the National Academy of Sciences of the United States of America, 83, 1817-1821.
12. Nicolson G. (1984) Cell surface molecules and tumor metastasis. Regulation of metastatic phenotypic diversity. Experimental Cell Research, 150, 3-22.
13. Plucinsky M. C., Riley W. M., Prorok J. J. and Alhadeff J. A. (1986) Total and lipid associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement. Cancer, 58, 2680-2685.
14. Raynes J. G. (1983) Serum concentrations of lipid-bound sialic acid and acute phase proteins in patients with cancer and non malignant disease. Biomèdicine et Pharmacothèrapie, 37, 136-138.
15. Santamaria L., Pizzala R., Galloto G. B., Benazzo M., Dianchi A., Casella M. C., Blanchi G., Ambanelli U. and Santagati G. (1987) Serum lipid sialic acid (LASA) test in detection and monitoring of malignancies paraneoplastic and rheumatoid syndromes. In: Human Tumor Markers, edited by Cimino, Birkmayer, Klavins, Pimentel, Salvatore, pp. 831-841. Berlin, New York, Walter de Gruyter and Co.
16. Shamberger R. J. (1984) Serum sialic acid in normal and in cancer patients. Journal of Clinical Chemistry and Clinical biochemistry, 22, 647-651.
17. Silver H. K. B., Karim K. A., Salinas F. A. and Swenerton K. D. (1981) Significance of sialic acid and carcinoemhryonic antigen as monitors of tumor burden among patients with carcinoma of the ovary. Surgery, Gynecology and Obstetrics, 153, 209-213.
18. Silver H. K. B., Murray R. N., Worth A. J., Salinas F. A. and Spinelli J. J. (1983) Prediction of malignant melanoma recurrence by serum N-acetylneuraminic acid. International Journal of Cancer, 31, 39-43.
19. Stefanelli N., Klotz H., Engel A. and Bauer P. (1985) Serum sialic acid in malignant tumors, bacterial infections and chronic liver diseases. Journal of Cancer Research and Clinical Oncology, 109, 55-59.
20. Svennherolm L. (1962) Quantitative estimation of sialic acid. III. An anion exchange resin method. Acta Chemica Scandinavica, 37, 105-107.
21. Vegh Z., Kremmer T., Boldizsar M., Gesztest K. A. and Szajani B. (1991) A re-evaluation of the lipid-bound sialic acid determination. Clinica Chimica Acta, 203, 259-268.
22. Vesce F., Biondi C., Gulinati A. M., Zeni C., Simonetti V. and Salvatorelli G. (1985) In vitro effect of progesterone on α-fucosidase activity of human endometrium. European Journal of Gynaecological Oncology, 6, 154-156.
23. Vitaioli L., Ricci R., Bellini L., Baldoni E., Antuzzi D. and Bolognani L. (1990) Sialic acid and neuraminidase activity in the frog oviduct: comparative biochemical investigation in the different tracts during the reproductive cycle. Comparative Biochemistry and Physiology, B '95, 35-38.
24. Vitaioli L., Baldoni E., Ricci R, and Indraccolo S. R. (1994) Expression of acidic glycosphingolipids and arylsulphatase A activity in human pathological endometrium. European Journal of Obstetrics and Gynecology and Reproductive Biology, 54, 31-35.
25. Vivas I., Spagnuolo L. and Palacios P. (1992) Total and lipid-bound serum sialic acid as markers for carcinoma of the uterine cervix. Gynecologic Oncology, 46, 157-162.
26. Voigtmann R., Pokorny J. and Meinshansen A. (1989) Evaluation and limitations of the lipid-associated sialic acid test for the detection of human cancer. Cancer, 64, 2279-2283.
27. Warren L. (1959) The thiobarbituric acid assay of sialic acids. Journal of Biological Chemistry, 234, 1971-1975.
28. Yogeeswaran G. (1983) Cell surface glycolipids and glycoproteins in malignant transformation. Advances in Cancer Research, 38, 289-350.